P&G to discuss Metamucil brand in webisode
CINCINNATI Procter & Gamble will begin emphasizing the point of difference of its Metamucil fiber supplement brand beginning March 1 with a new television commercial and webisode.
Metamucil is the one of the only fiber supplement brands made with psyllium fiber, which gels to help remove waste and reduce cholesterol.
New packaging will also debut this summer that will emphasize Metamucil as a “Multi-Health Fiber,” calling attention to some of the lesser-known health benefits of Metamucil, such as its its cholesterol lowering benefit.
CDC, Arthritis Foundation seek to raise awareness about osteoarthritis
WASHINGTON The Centers for Disease Control and Prevention and the Arthritis Foundation in early February announced a major initiative to dramatically reduce the impact of osteoarthritis on Americans. In conjunction with the announcement, the Arthritis Foundation and the Ad Council are unveiling a national public awareness campaign in response to the recommendations outlined in the action plan, "A National Public Health Agenda for Osteoarthritis."
The Agenda is the result of an 18-month effort by the CDC and the Arthritis Foundation that included the development of two working groups, one focusing on research interventions and the other on policy/communications efforts, and a major summit that brought together more than 75 stakeholders to determine the best strategies for reducing the impact of osteoarthritis.
“This important report will help the public health community speak with a unified voice and focus our collective efforts on actions that we know will make a difference in the lives of people suffering from osteoarthritis,” stated Ursula Bauer, director of CDC’s National Center for Chronic Disease Prevention and Health Promotion.
Already the nation’s most common cause of disability, the impact of arthritis is slated to increase in the decades to come. One-in -ive adults in the United States (46 million people) has arthritis and an estimated 67 million people will be affected by 2030.
Osteoarthritis, the most common form of arthritis, is a serious and painful joint disease that currently affects nearly 27 million people in the United States and costs an estimated $5,700 annually per person living with the disease. With the combination of inactivity, obesity, injury and the aging of Americans, the rising prevalence of osteoarthritis is expected to escalate the severe health and economic effects of this disease.
LifeScan recalls lots of glucose test strips
MILPITAS, Calif. LifeScan on Wednesday issued a voluntary recall in the United States of eight lots of OneTouch SureStep test strips, used by people with diabetes to measure their blood glucose levels at home.
The test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL, Johnson & Johnson stated. LifeScan estimated approximately 14,000 packages (50- and 100-count) of consumer OneTouch SureStep Test Strips were distributed nationwide between Aug. 1, 2009, and Jan. 28, 2010.
Patients with test strips from the recalled lots are asked to call LifeScan at 1-800 574-6139 between 5:00 am and 7:00 pm Pacific Time, seven days a week or visit www.SureStep.com to request replacement product. Replacement product will be shipped immediately and provided free of charge.
The eight lots of consumer OneTouch SureStep Test Strips being recalled are:Recalled Lot Size Description # 2969251 100-ct OneTouch SureStep# 2969798 100-ct OneTouch SureStep# 2982369 100-ct OneTouch SureStep# 2983467 100-ct OneTouch SureStep# 2969795 50-ct OneTouch SureStep# 2982566 50-ct OneTouch SureStep# 2969481 50-ct Medicare/Mail Order# 2998193 50-ct Medicare/Mail Order
Lot #’s are located on the outer carton and test strip vial.